Creation of de novo cryptic splicing for ALS and FTD precision medicine

Oscar G. Wilkins(The Francis Crick Institute), Pietro Fratta(MRC Prion Unit)
Science
October 3, 2024
10.1126/science.adk2539
Cited by 30

Related Papers

TDP-43 loss and ALS-risk SNPs drive mis-splicing and depletion of UNC13A
|Nature|2022|510
Cell environment shapes TDP-43 function with implications in neuronal and muscle disease
|Communications Biology|2022|52
Creation of de novo cryptic splicing for ALS/FTD precision medicine
|bioRxiv (Cold Spring Harbor Laboratory)|2023|5